<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2106222237
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1997
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PROFINAL 600 mg tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        IBUPROFEN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        600
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        10.75
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AE01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Profinal</strong> belong to a group of medicines called anti-inflammatory pain killers. They can be used to relieve pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis (including juvenile rheumatoid arthritis or Still&rsquo;s disease), arthritis of the spine (ankylosing spondylitis), swollen joints, frozen shoulder, bursitis, tendinitis, tenosynovitis, lower back pain, sprains and strains.</p><p><strong>Profinal</strong> can also be used to treat other painful conditions such as toothache, pain after operations, period pain and headache, including migraine.</p><p>The active ingredient in <strong>Profinal</strong> is ibuprofen and each tablet contains either 200, 400 or 600 mg.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>If the answer to any of the following questions is &lsquo;YES&rsquo; please tell your doctor or pharmacist BEFORE taking any Profinal tablets:</strong></p><p>&middot;&nbsp; Are you pregnant or planning to become pregnant, or are you breast-feeding? <strong>Profinal</strong> may make it more difficult to become pregnant. You should inform your doctor if you are planning to become pregnant or if you have problems becoming pregnant.</p><p>&middot;&nbsp; Are you sensitive (allergic) to any of the ingredients in the tablets? These are listed in Section 6.</p><p>&middot;&nbsp; Do you have, or have you previously had, a stomach ulcer or other gastric complaint?<br />Do not take <strong>Profinal</strong> if you currently have a peptic ulcer (ulcer in your stomach or duodenum) or bleeding in your stomach, or have had two or more episodes of peptic ulcers, stomach bleeding or perforation in the past.</p><p>NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events.&nbsp;</p><p>&middot;&nbsp; Do you have a condition which increases your tendency to bleeding?</p><p>&middot;&nbsp; Do you suffer from asthma or have you ever had an allergic reaction or suffered from wheezing after taking ibuprofen, aspirin or other anti-inflammatory pain killers?</p><p>&middot;&nbsp; Do you suffer from liver or kidney disease?</p><p>&middot;&nbsp; Do you suffer from heart disease?</p><p>Medicines such as ibuprofen may be associated with a small increased risk of heart attack (myocardial infarction) or stroke. Any risk is more likely with high doses and prolonged treatment. Do not exceed the recommended dose or duration of treatment. If you have heart problems, previous stroke or think that you might be at risk of these conditions (e.g. if you have high blood pressure, diabetes, high cholesterol or are a smoker) you should discuss your treatment with your doctor or pharmacist.</p><p>NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease<strong> </strong>or risk factors for cardiovascular disease may be at greater risk. NSAIDs are contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery. <strong>&nbsp;</strong></p><p>&middot;&nbsp; Do you have systemic lupus erythematosus (SLE, sometimes known as lupus) or a connective tissue disease (autoimmune diseases affecting connective tissue)?</p><p>&middot;&nbsp; Have you been told by your doctor that you have an intolerance to some sugars?</p><p>&middot;&nbsp; There is a risk of kidney damage in dehydrated children and adolescents.</p><p><strong>Can you take Profinal with other medicines?</strong>&nbsp;</p><p>Some medicines that are anti-coagulants (i.e. thin blood/prevent clotting e.g. aspirin/ acetylsalicyclic acid, warfarin, ticlodipine), some medicines that reduce high blood pressure (ACE-inhibitors such as captopril, beta-blockers such as atenolol, or angiotensin-II receptor antagonists such as losartan) and other medicines may affect or be affected by treatment with ibuprofen. You should therefore always seek the advice of your doctor or pharmacist before you use ibuprofen with other medicines.</p><p>In particular you should tell your doctor or pharmacist if you are taking any of the following medicines in addition to those mentioned above:</p><p>&middot;&nbsp; diuretics (water tablets)</p><p>&middot;&nbsp; cardiac glycosides, such as digoxin, used to treat heart conditions</p><p>&middot;&nbsp; lithium</p><p>&middot;&nbsp; zidovudine (an anti-viral drug)</p><p>&middot;&nbsp; steroids (used in the treatment of inflammatory conditions)</p><p>&middot;&nbsp; methotrexate (used to treat certain cancers)</p><p>&middot;&nbsp; medicines known as immunosuppressants such as ciclosporin and tacrolimus (used to dampen down your immune response)</p><p>&middot;&nbsp; medicines known as selective serotonin reuptake inhibitors (SSRIs), used for the treatment of depression</p><p>&middot;&nbsp; antibiotics called quinolones such as ciprofloxacin</p><p>&middot;&nbsp; aminoglycosides (a type of antibiotic)</p><p>&middot;&nbsp; mifepristone</p><p>&middot;&nbsp; any other ibuprofen preparations, such as those you can buy without a prescription</p><p>&middot;&nbsp; any other anti-inflammatory pain killer, including aspirin</p><p>&middot;&nbsp; cholestyramine (a drug used to lower cholesterol)</p><p>&middot;&nbsp; medicines known as sulphonylureas such as glibenclamide (used to treat diabetes)</p><p>&middot;&nbsp; voriconazole or fluconazole (types of anti-fungal drugs)</p><p>&middot;&nbsp; Gingko biloba herbal medicine (there is a chance you may bleed more easily if you are taking this with ibuprofen).</p><p><strong>Pregnancy and breast-feeding:</strong>&nbsp;The use of <strong>Profinal</strong> whilst pregnant or breast feeding should be avoided.</p><p><strong>Profinal</strong> should not be used in late (the last three months) of pregnancy and should only be taken in the first six months of pregnancy on the advice of your doctor.</p><p><strong>Driving and Using Machines:</strong>&nbsp;<strong>Profinal</strong> may make you feel dizzy or drowsy. If the tablets affect you in this way do not drive, operate machinery or do anything that requires you to be alert.</p><p><strong>Important information about some of the ingredients of </strong><strong>Profinal</strong></p><p><strong>Profinal</strong> 400mg and 600mg tablets contain lactose. If you have been told by your doctor that you cannot tolerate some sugars; talk to your doctor before taking this medicine</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>ALWAYS</strong>&nbsp;take <strong>Profinal</strong> exactly as your doctor has told you. If you are not sure refer to the label on the carton or check with your doctor or pharmacist.</p><p>Take your <strong>Profinal</strong> tablets with or after food, with a glass of water. <strong>Profinal</strong> tablets should be swallowed whole and not chewed, broken, crushed or sucked to help prevent discomfort in the mouth or irritation in the throat.</p><p><strong>Dosage:</strong></p><p><strong>Adults -</strong>&nbsp;The usual dosage is 600 to 1800 mg spread throughout the day. Your doctor may choose to increase this depending on what you are being treated for, but no more than 2400 mg should be taken in one day.</p><p><strong>Children -</strong>&nbsp;The usual daily dosage is 20 mg per kg of bodyweight, given in divided doses. <strong>Profinal</strong> Tablets should&nbsp;<strong>NOT</strong>&nbsp;be taken by children weighing less than 7 kg.</p><p>In cases of severe juvenile arthritis your doctor may increase the dosage up to 40 mg/kg in divided doses.</p><p><strong>If you take more </strong><strong>Profinal</strong><strong> tablets than prescribed (an overdose)</strong></p><p>You should contact a doctor or go to the nearest hospital casualty department&nbsp;<strong>IMMEDIATELY</strong>&nbsp;taking your tablets with you.</p><p><strong>If you forget to take your </strong><strong>Profinal</strong><strong> tablet</strong></p><p>Take them as soon as you remember, unless it is almost time for your next dose. If it is, do not take the missed dose at all. Never double up on a dose to make up for the one you have missed.</p><p><strong>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>As with all medicines, <strong>Profinal</strong> may cause side effects, although they are usually mild and not everyone will suffer from them. If any side effects become serious or if you notice any side effects that are not listed in this leaflet, please tell your doctor or pharmacist. You can minimize the risk of side effects by taking the least amount of tablets for the shortest amount of time necessary to control your symptoms.</p><p><strong>&nbsp;</strong></p><p><strong>If you suffer from any of the following at any time during your treatment STOP TAKING Profinal tablets and&nbsp;<em>seek immediate medical help:</em></strong></p><p>&middot;&nbsp; Severe headache, high temperature, stiffness of the neck or intolerance to light</p><p>&middot;&nbsp; Pass blood in your faeces (stools/motions)</p><p>&middot;&nbsp; Pass black tarry stools</p><p>&middot;&nbsp; Vomit any blood or dark particles that look like coffee grounds.</p><p><strong>Tell your doctor and stop taking Profinal if you experience:</strong></p><p>&middot;&nbsp; Severe spreading skin rash (Stevens-Johnson Syndrome and erythema multiforme, symptoms include severe skin rash, blistering of skin, including inside mouth, nose, and genitals, as well as skin peeling which may be accompanied with symptoms such as aching, headaches, and feverishness).&nbsp;</p><p>&middot;&nbsp; Medicines such as ibuprofen have in exceptional cases been associated with severe skin problems for patients with chicken pox or shingles</p><p>&middot;&nbsp; Blood disorders, kidney problems, liver problems or severe skin reactions may occur rarely with Ibuprofen.</p><p>&middot;&nbsp; Very rarely ibuprofen tablets may cause aseptic meningitis (inflammation of the protective membrane surrounding the brain).</p><p>&middot;&nbsp; Ibuprofen has also been shown to sometimes worsen the symptoms of Crohns disease or colitis.</p><p><strong>&nbsp;Other side effects</strong></p><p><strong>Common</strong> (affects up to 1 in 10 people):</p><p>&middot;&nbsp; Rash</p><p>&middot;&nbsp; Feeling dizzy or tired</p><p>&middot;&nbsp; Stomach pain, indigestion, diarrhea, feeling sick, being sick, wind, constipation</p><p>&middot;&nbsp; Headache- if this happens while you are taking this medicine it is important not to take any other medicines for pain to help with this</p><p>&middot;&nbsp; Passing black tarry stools</p><p>&middot;&nbsp; Passing blood in your feces (stools/motions)</p><p>&middot;&nbsp; Vomiting any blood</p><p><strong>Uncommon</strong> (affects up to 1 in 100 people)</p><p>&middot;&nbsp; Feeling drowsy</p><p>&middot;&nbsp; Feeling anxious</p><p>&middot;&nbsp; Feeling a tingling sensation or &lsquo;pins and needles&rsquo;</p><p>&middot;&nbsp; Difficulty sleeping</p><p>&middot;&nbsp; Hives, itching</p><p>&middot;&nbsp; Skin becomes sensitive to light</p><p>&middot;&nbsp; Visual disturbances, hearing problems</p><p>&middot;&nbsp; Hepatitis, yellowing of your skin or eyes, reduced liver function</p><p>&middot;&nbsp; Reduced kidney function, inflammation of the kidneys, kidney failure</p><p>&middot;&nbsp; Sneezing, blocked, itchy or runny nose (rhinitis)</p><p>&middot;&nbsp; Stomach or gut ulcer, hole in the wall of the digestive tract</p><p>&middot;&nbsp; Inflammation of your stomach lining</p><p>&middot;&nbsp; Small bruises on your skin or inside your mouth, nose or ears</p><p>&middot;&nbsp; Difficulty breathing, wheezing or coughing, asthma or worsening of asthma</p><p>&middot;&nbsp; Ringing in ears (tinnitus)</p><p>&middot;&nbsp; Sensation of feeling dizzy or spinning (vertigo)</p><p>&middot;&nbsp; Mouth ulcers</p><p>&middot;&nbsp; Serious allergic reaction which causes swelling of the face or throat</p><p><strong>Rare</strong> (affects up to 1 in 1000 people)</p><p>&middot;&nbsp; Feeling depressed or confused</p><p>&middot;&nbsp; Fluid retention (edema)</p><p>&middot;&nbsp; &nbsp;A brain infection called &lsquo;non-bacterial meningitis&rsquo;</p><p>&middot;&nbsp; &nbsp;Loss of vision</p><p>&middot;&nbsp; Changes in blood count-the first signs are: high temperature, sore throat, mouth ulcers, flu-like symptoms, feeling very tired, bleeding from the nose and the skin</p><p>&middot;&nbsp; &nbsp;Reduction in blood cells (anemia)</p><p>&middot;&nbsp; Serious allergic reaction which causes difficulty in breathing or dizziness</p><p>&middot;&nbsp; Severe sore throat with high fever (agranulocytosis)</p><p><strong>&nbsp;Very rare</strong> (affects up to 1 in 10,000 people)</p><p>&middot;&nbsp; Live failure</p><p>&middot;&nbsp; Heart failure</p><p>&middot;&nbsp; Inflammation of the pancreas</p><p>&middot;&nbsp; Skin problems (which can also affect inside your mouth, nose or ears) such as &lsquo;Stevens-Johnson syndrome&rsquo;, &lsquo;toxic epidermal necrolysis&rsquo; or &lsquo;erythema multiforme&rsquo;</p><p>&middot;&nbsp; High blood pressure&nbsp;</p><p><strong>Not known</strong> (frequency cannot be estimated from available data(</p><p>&middot;&nbsp; Worsening of ulcerative colitis or crohns disease (inflammation of the colon)</p><p>&nbsp;</p><p><strong><u>To report any side effect(s): </u></strong></p><p>&middot;&nbsp; <strong>Saudi Arabia:</strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax:</strong> +966-11-205-7662</p><p><strong>Call NPC at</strong> +966-11-2038222</p><p><strong>Exts:</strong> 2317-2356-2353-2354-2334-2340</p><p><strong>Toll free phone:</strong> 8002490000</p><p><strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p><strong>Website:</strong> www.sfda.gov.sa/npc</p><p>&middot;&nbsp; <strong>Other GCC States:</strong> &nbsp;Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp; Do not take <strong>Profinal </strong>after the expiry date which is stated on the carton and on the blister.</p><p>-&nbsp; <em>Do not store above 30&ordm;C.</em></p><p>-&nbsp; Do not take <strong>Profinal </strong>if you notice any visible sign of deterioration.</p><p>-&nbsp; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Each film-coated tablet contains:</p><p><strong><u>Profinal 200 </u></strong></p><p><em>Active ingredient:</em> &nbsp;Ibuprofen &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;200mg</p><p><em>Excipients:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>Starch, stearic acid, colloidal silicon dioxide, microcrystalline cellulose, polyvinyl pyrrolidone, croscarmellose sodium, hypromellose, polyethylene glycol, talc and titanium dioxide.</p><p><strong><u>Profinal 400</u></strong></p><p><em>Active ingredient:</em> &nbsp;Ibuprofen &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;400mg</p><p>Excipients:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Starch, stearic acid, colloidal silicon dioxide, microcrystalline cellulose, polyvinyl pyrrolidone, croscarmellose sodium, hypromellose, lactose, titanium dioxide, polyethylene glycol, lake food red no. 7, carmoisine, FD&amp;C blue no. 2, and simethicone.</p><p><strong><u>Profinal 600</u></strong></p><p><em>Active ingredient:</em> &nbsp;Ibuprofen&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 600mg</p><p>Excipients:&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Starch, stearic acid, colloidal silicon dioxide, microcrystalline cellulose, polyvinyl pyrrolidone, croscarmellose sodium, talc, hypromellose, lactose, titanium dioxide, polyethylene glycol, lake food red no. 7, carmoisine, FD&amp;C blue no. 2, and simethicone.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                
Profinal 200mg film-coated tablets are available in packs of 20, 250, 500 and 1000 film-coated tablets. 
Profinal 400mg film-coated tablets are available in packs of 24, 240 and 1000 film-coated tablets.
Profinal 600mg film-coated tablets are available in packs of 20, 40 and 250 film-coated tablets.



            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot; Julphar&quot;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                24/04/2016
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>ينتمي <strong>بروفينال</strong> إلى مجموعة من الأدوية المعروفة باسم مضادات الالتهاب المسكنة للألم. وهي تستخدم لتخفيف الألم والالتهاب في حالات مثل التهاب المفاصل العظمي، التهاب المفاصل الروماتويدي (بما في ذلك التهاب المفاصل الروماتويدي الصبياني أو داء ستيل)، التهاب المفاصل في العمود الفقري (التهاب الفقار القسطي)، تورم المفاصل، الكتف المتجمدة، الالتهاب الكيسي الزلالي، التهاب الأوتار، التهاب غمد الوتر، الألم في أسفل الظهر، وحالات الالتواء والإجهاد.</p><p>كما يستخدم <strong>بروفينال</strong> لعلاج الحالات الأخرى المصحوبة بألم مثل ألم الأسنان، الألم الذي يحدث عقب العمليات الجراحية، وآلام الدورة الشهرية والصداع، بما في ذلك الصداع النصفي (الشقيقة).</p><p>إن المادة الفعالة في <strong>بروفينال</strong> هي آيبوبروفين ويحتوي كل قرص على 200 ملغم، 400 ملغم أو 600 ملغم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>إذا كانت إجابتك لأياً من الأسئلة التالية &rsquo;نعم‛، فيرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول أقراص بروفينال:</strong></p><p>&middot;&nbsp; هل أنتِ حامل أو تخططين لتصبحين حامل، أو ترضعين طفلك رضاعة طبيعية؟ قد يعيق <strong>بروفينال</strong> حدوث الحمل بدرجة كبيرة. يجب عليك إخبار طبيبك المعالج فيما إذا كنت تخططين لتصبحين حامل أو إذا كنت تعانين من مشاكل تعيق حدوث الحمل.</p><p>&middot;&nbsp; هل تعاني من الحساسية تجاه أيا من مكونات الأقراص؟ وهي مذكورة في الفقرة 6.</p><p>&middot;&nbsp; هل تعاني أو عانيت مسبقاً من قرحة في المعدة أو شكوى أخرى في المعدة؟</p><p>يجب عدم تناول <strong>بروفينال</strong> إذا كنت تعاني في الوقت الحالي من قرحة هضمية (قرحة في المعدة أو الاثنى عشر) أو من نزيف في المعدة، أو عانيت&nbsp; فيما مضى من حدوث نوبتين أو أكثر للقرحة الهضمية، أو عانيت مسبقاً من نزيف أو انثقاب في المعدة.</p><p>إن الأدوية غير الستيرويدية المضادة للالتهابات قد تتسبب في زيادة خطر حدوث التأثيرات الجانبية الخطيرة المعدية- المعوية &nbsp;بما في ذلك النزيف، التقرح، وحدوث ثقب في المعدة أو الأمعاء، التي من الممكن أن تكون مهددة للحياة. إن هذه التأثيرات يمكن أن تحدث في أي وقت أثناء تناول هذا الدواء ودون أعراض تحذيرية. المرضى من فئة كبار السن هم الأكثر عرضة لحدوث مخاطر الجهاز الهضمي.</p><p>&middot;&nbsp; هل تعاني من مشكلة ما تزيد من خطر حدوث نزيف؟</p><p>&middot;&nbsp; هل تعاني من من داء الربو أو عانيت مسبقاً من تفاعل تحسسي أو عانيت من حدوث أزيز بعد تناول آيبوبروفين، أسبرين أو أياً من الأدوية المضادة للالتهاب المسكنة للألم؟&nbsp;</p><p>&middot;&nbsp; هل تعاني من مرض في الكبد أو الكلى؟</p><p>&middot;&nbsp; هل تعاني من مرض في القلب؟</p><p>إن الأدوية مثل آيبوبروفين قد يصاحب تناولها زيادة طفيفة في خطر حدوث الأزمات القلبية (احتشاء عضلة القلب) أو السكتة الدماغية. من المحتمل زيادة حدوث أية مخاطر مع الجرعات العالية وفترات العلاج الطويلة.</p><p>يجب عدم تجاوز الجرعات الموصى بها أو مدة العلاج.</p><p>إذا كنت تعاني من مشكلات في القلب، أو عانيت مسبقاً من السكتة الدماغية أوإذا كنت تعتقد بأنك عرضة لخطر حدوث مثل هذه الحالات (على سبيل المثال، إذا كنت تعاني من ارتفاع ضغط الدم، داء السكري أو ارتفاع مستوى الكوليسترول في الدم، أو إذا كنت مدخناً). يجب عليك مناقشة أمر علاجك مع طبيبك المعالج أو الصيدلي الذي تتعامل معه.</p><p>قد تزيد الأدوية غير الستيرويدية المضادة للالتهابات من خطر حدوث جلطات القلب والأوعية الدموية، الذبحة القلبية، والسكتة الدماغية والتي قد تكون مهددة للحياة. ويزداد هذا الخطر مع زيادة فترة الاستعمال. ولكن المرضى الذين يعانون من أمراض القلب والأوعية الدموية أو عوامل خطورتها أكثر عرضة لهذا الخطر. يحذر تناول الأدوية غير الستيرويدية المضادة للالتهابات لعلاج الألم ما قبل الجراحة الالتفافية للشريان التاجي.</p><p>&middot;&nbsp; هل تعاني من الذئبة الحمامية الجهازية (تسمى أحياناً الذئبة) أو مرض في النسيج الضام (مرض مناعي ذاتي يؤثر على النسيج الضام)؟</p><p>&middot;&nbsp; هل أخبرك طبيبك المعالج من قبل بأنك تعاني من عدم القدرة على تحمل بعض أنواع السكر؟</p><p>&middot;&nbsp; المرضى من فئة الأطفال والمراهقين الذين يعانون من الجفاف معرضون لحدوث تلف في الكلى.</p><p><strong>هل بإمكانك تناول بروفينال مع أدوية أخرى؟</strong></p><p>إن بعض الأدوية مثل الأدوية المضادة للتجلط (تعمل على ترقيق الدم/منع التخثر مثل الأسبرين/حمض أسيتيل ساليسيلك، وارفارين، تكلوديبين)، وبعض الأدوية التي تخفض ضغط الدم المرتفع (مثبطات الإنزيم المحول للأنجيوتنسين مثل كابتوبريل، غالقات مستقبلات بيتا مثل الأتينولول، أو الأدوية المضادة لمستقبلات أنجيوتنسين 2 مثل لوسارتان) وغيرها من الأدوية قد تؤثر على فعالية آيبوبروفين، كما قد يؤثر آيبوبروفين على فعالية هذه الأدوية. لذا يجب عليك دائماً استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول آيبوبروفين مع الأدوية الأخرى.</p><p>وبصفة خاصة، يجب عليك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول أياً من الأدوية التالية بالإضافة إلى تلك الأدوية المذكورة أعلاه:&nbsp; &nbsp;&nbsp;</p><p>&middot;&nbsp; مدرات البول (الأدوية التي تحفز طرح البول)</p><p>&middot;&nbsp; الجلايكوسيدات القلبية، مثل ديجوكسين، الذي يستخدم لعلاج مشاكل القلب</p><p>&middot;&nbsp; الليثيوم</p><p>&middot;&nbsp; زيدوفودين (دواء مضاد للفيروسات)</p><p>&middot;&nbsp; الستيرويدات (أدوية تستخدم لعلاج الالتهابات)</p><p>&middot;&nbsp; ميثوتركسات (دواء يستخدم لعلاج بعض أنواع السرطان)</p><p>&middot;&nbsp; أدوية تعرف بمثبطات المناعة مثل سيكلوسبورين وتاكروليمس (أدوية تستخدم للحد من ردود فعل الجهاز المناعي في الجسم في بعض الحالات).</p><p>&middot;&nbsp; أدوية تعرف بمثبطات إعادة أخذ السيروتونين الانتقائية، وهي أدوية تستخدم لعلاج الاكتئاب</p><p>&middot;&nbsp; مضادات حيوية تعرف بمجموعة الكينولون مثل سيبروفلوكساسين</p><p>&middot;&nbsp; الأمينوجلايكوسيدات (نوع من المضادات الحيوية)</p><p>&middot;&nbsp; ميفيبرستون</p><p>&middot;&nbsp; أي شكل آخر من أشكال الآيبوبروفين، مثل تلك المستحضرات التي يمكنك شراؤها بدون وصفة طبية</p><p>&middot;&nbsp; أي دواء آخر من الأدوية المضادة للالتهاب المسكنة للألم، بما في ذلك الأسبرين</p><p>&middot;&nbsp; كوليستيرامين (دواء يستخدم لخفض الكوليسترول في الدم)</p><p>&middot;&nbsp; أدوية تعرف بمجموعة السلفونيل يوريا مثل جلايبنكلاميد (يستخدم لعلاج داء السكري)</p><p>&middot;&nbsp; فوريكونازول أو فلوكونازول (أدوية مضادة للفطريات)</p><p>&middot;&nbsp; المستحضر العشبي جنكو بيلوبا (هناك فرصة لحدوث النزيف بصورة أسهل إذا ما تناولت هذا المستحضر بالتزامن مع آيبوبروفين)</p><p><strong>الحمل والرضاعة الطبيعية: </strong>يجب تجنب تناول <strong>بروفينال</strong> أثناء فترة الحمل أو الرضاعة الطبيعية.</p><p>يجب تجنب تناول <strong>بروفينال</strong> خلال الأشهر الثلاثة الأخيرة من الحمل، ويجب تناوله خلال الستة أشهر الأولى من الحمل فقط إذا أوصى طبيبك المعالج بذلك.&nbsp;&nbsp;&nbsp;&nbsp;</p><p><strong>القيادة واستخدام الآلات:</strong><strong> </strong>قد يتسبب <strong>بروفينال </strong>في حدوث دوخة أو نعاس. يجب عليك تجنب القيادة أو تشغيل الآلات أو فعل أي شيء يتطلب منك اليقظة في حال حدوث مثل هذه التأثيرات.</p><p><strong>معلومات هامة حول بعض مكونات بروفينال</strong></p><p>تحتوي أقراص <strong>بروفينال</strong> 400ملغم&nbsp; و600 ملغم على اللاكتوز. يرجى منك استشارة طبيبك المعالج قبل أن تتناول هذا الدواء، إذا كان قد أخبرك مسبقاً بأنك تعاني من مشكلة تتمثل في عدم القدرة على تحمل بعض أنواع السكر.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يجب عليك دائماً تناول أقراص <strong>بروفينال</strong> بدقة تبعاً لتعليمات طبيبك المعالج. إذا لم تكن متأكداً من ذلك، فيرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه. يمكن تناول أقراص <strong>بروفينال</strong> أثناء أو بعد تناول الطعام مع كوباً من الماء. يجب عليك بلع الأقراص كاملةً دون مضغها أو كسرها أو سحقها أو مصها، حتى لا تسبب ألماً في الفم أو تهيج في الحلق.</p><p><strong>الجرعة: </strong></p><p><strong>البالغون-</strong> يبلغ مقدار الجرعة الاعتيادية 600 إلى 1800 ملغم تعطى مقسمة خلال اليوم. قد يقوم طبيبك المعالج بزيادة الجرعة اعتماداً على نوع المرض الذي تتلقى العلاج من شأنه، بحيث عدم تجاوز الجرعة 2400 ملغم في اليوم الواحد.&nbsp;</p><p><strong>الأطفال-&nbsp; </strong>يبلغ مقدار الجرعة الاعتيادية 20 ملغم لكل كيلوغرام من وزن الجسم، ويتم إعطائها على جرعات مقسمة. يجب عدم تناول أقراص <strong>بروفينال </strong>من قبل الأطفال الذين يزنون أقل من 7 كيلوغرام.</p><p>في حال التهاب المفاصل الصبياني الشديد سيقوم الطبيب المعالج بزيادة مقدار الجرعة لتصل إلى 40 ملغم/ كيلوغرام في جرعات مقسمة.</p><p><strong>إذا تناولت جرعة أكبر من الجرعة المحددة لك (جرعة مفرطة)</strong></p><p>يجب عليك التواصل مع طبيبك المعالج أو التوجه إلى قسم الطوارىء بأقرب مستشفى <strong>على الفور</strong>، مع أخذ أقراص الدواء معك.</p><p><strong>إذا سهوت عن تناول جرعة من بروفينال</strong></p><p>يجب عليك تناولها في أسرع وقت في حال تذكرها، إلا إذا اقترب موعد الجرعة التالية، فيستحسن الاستمرار في جدول الجرعات دون أخذ الجرعة التي قد سهوت عن تناولها.<strong> </strong></p><p>يجب عليك عدم تناول جرعتين في آن واحد، لتعويض عن الجرعة المفردة التي قد سهوت عن تناولها.</p><p><strong>يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه، إذا كان لديك أية أسئلة إضافية حول استخدام هذا الدواء.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كما هو الحال مع جميع الأدوية، قد يسبب <strong>بروفينال</strong> حدوث تأثيرات جانبية، على الرغم من ذلك &nbsp;عادةً ما تكون طفيفة وقد لا تحدث لكل شخص. يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه في حال زيادة حدة أياً من التأثيرات الجانبية أو ملاحظة أية تأثيرات جانبية لم تذكر في هذه النشرة. يمكنك الحد من خطر حدوث التأثيرات الجانبية للدواء عن طريق تناول أقل كمية ممكنة من الأقراص خلال أقصر فترة زمنية تتطلب للسيطرة على الأعراض.</p><p><strong>يرجى منك التوقف عن تناول أقراص بروفينال واطلب المشورة الطبية على الفور، في حال تعرضك لأحد التأثيرات الجانبية التالية في أي وقت خلال فترة العلاج</strong><strong>:</strong></p><p>&middot;&nbsp; صداع شديد، ارتفاع في درجة الحرارة، وتصلب في الرقبة أو عدم القدرة على تحمل الضوء</p><p>&middot;&nbsp; براز دموي</p><p>&middot;&nbsp; براز ذو لون أسود</p><p>&middot;&nbsp; قيء دموي أو قيء يحتوي على جزيئات داكنة اللون شبيهة بحبوب القهوة</p><p><strong>يرجى منك إخبار طبيبك المعالج والتوقف عن تناول بروفينال إذا حدثت لك أياً من الأعراض التالية:</strong></p><p>&middot;&nbsp; طفح جلدي شديد منتشر على مساحات واسعة من الجسم (متلازمة ستيفن جونسون وحمامي متعدد الأشكال، وتتضمن الأعراض على طفح جلدي شديد، ظهور تقرحات جلدية ، بما في ذلك داخل الفم، الأنف والأعضاء التناسلية، وكما تتضمن على&nbsp; تقشر الجلد الذي من الممكن أن يكون مصحوباً &nbsp;بحدوث أعراض على سبيل المثال آلام، صداع، و ارتفاع حرارة الجسم).</p><p>&middot;&nbsp; إن بعض الأدوية على سبيل المثال آيبوبروفين قد ترتبط استعمالها بحدوث مشاكل جلدية لدى المرضى الذين يعانون من جدري الماء والهربس النطاقي</p><p>&middot;&nbsp; قد تحدث بصورة نادرة اضطرابات في الدم، مشاكل في الكلى، مشاكل في الكبد أو تفاعلات جلدية شديدة عند تناول آيبوبروفين.</p><p>&middot;&nbsp; وبصورة نادرة جداً، قد يسبب آيبوبروفين التهاب السحايا العقيم (التهاب الغشاء الواقي المحيط بالدماغ).&nbsp;&nbsp;</p><p>&middot;&nbsp; كما أظهر آيبوبروفين أنه يسبب في بعض الأحيان تفاقم لأعراض مرض كرون أو التهاب القولون.</p><p><strong>التأثيرات الجانبية الأخرى</strong></p><p><strong>شائعة </strong>(تؤثر على ما يصل إلى شخص واحد من كل 10 أشخاص)</p><p>&middot;&nbsp; طفح جلدي</p><p>&middot;&nbsp; الشعور بالدوخة أو بالتعب</p><p>&middot;&nbsp; ألم في المعدة، عسر الهضم، إسهال، شعور بالإعياء، توعك، ريح، إمساك</p><p>&middot;&nbsp; صداع- في حال حدوث ذلك خلال فترة تناول هذا الدواء، فمن المهم عدم تناول أدوية أخرى التي تستخدم لتخفيف الألم بالتزامن مع هذا الدواء</p><p>&middot;&nbsp; براز ذو لون أسود</p><p>&middot;&nbsp; براز دموي</p><p>&middot;&nbsp; قيء دموي</p><p><strong>غير شائعة </strong>(تؤثر على ما يصل إلى شخص واحد من كل 100 شخص)</p><p>&middot;&nbsp; الشعور بالنعاس</p><p>&middot;&nbsp; الشعور بالقلق</p><p>&middot;&nbsp; الشعور بالتنميل أو بالوخز كوخر الأبر والدبابيس</p><p>&middot;&nbsp; الصعوبة في النوم</p><p>&middot;&nbsp; طفح جلدي على شكل خلايا النحل، حكة</p><p>&middot;&nbsp; يصبح الجسم حساس تجاه الضوء</p><p>&middot;&nbsp; اضطراب في الرؤية، مشاكل في السمع</p><p>&middot;&nbsp; التهاب الكبد، اصفرار الجلد أو العينين، اضطراب وظائف الكبد</p><p>&middot;&nbsp; اضطراب وظائف الكلى، التهاب الكلى، فشل الكلى</p><p>&middot;&nbsp; العطاس، انسداد في الأنف، حكة في الأنف أو سيلان الأنف (التهاب الأنف)</p><p>&middot;&nbsp; قرحة في المعدة أو الأمعاء، انثقاب في جدار الجهاز الهضمي</p><p>&middot;&nbsp; التهاب في بطانة المعدة</p><p>&middot;&nbsp; ظهور كدمات صغيرة على الجلد أو داخل الفم، الأنف أو الأذن</p><p>&middot;&nbsp; صعوبة في التنفس، أزيز أو سعال، داء الربو، أو زيادة حدة داء الربو</p><p>&middot;&nbsp; طنين في الأذنين</p><p>&middot;&nbsp; الشعور بالدوخة أو بالدوار</p><p>&middot;&nbsp; تقرحات فموية</p><p>&middot;&nbsp; تفاعلات تحسسية خطيرة التي تؤدي إلى تورم الوجه أو الحلق</p><p><strong>نادرة </strong>(تؤثر على ما يصل إلى شخص واحد من كل 1000 شخص)</p><p>&middot;&nbsp; الشعور بالاكتئاب أو الارتباك</p><p>&middot;&nbsp; احتباس السوائل (وذمة)</p><p>&middot;&nbsp; عدوى في الدماغ تعرف باسم التهاب السحايا العقيم</p><p>&middot;&nbsp; فقدان البصر</p><p>&middot;&nbsp; تغيرات في تعداد الدم، حيث تتضمن الأعراض الأولية التي تدل على حدوث ذلك على: ارتفاع درجة الحرارة، احتقان الحلق، تقرحات فموية، أعراض شبيهة بأعراض الأنفلونزا، الشعور بالتعب الشديد، حدوث نزيف في الأنف والجلد</p><p>&middot;&nbsp; انخفاض في تعداد الدم (فقر الدم)</p><p>&middot;&nbsp; تفاعلات تحسسية خطيرة التي تؤدي إلى صعوبة في التنفس أو الدوخة</p><p>&middot;&nbsp; احتقان شديد في الحلق مصحوباً&nbsp; بارتفاع درجة الحرارة (كثرة المحببات)</p><p><strong>نادرة جداً</strong> (تؤثر على ما يصل إلى شخص واحد من كل 10000 شخص)</p><p>&middot;&nbsp; فشل الكبد</p><p>&middot;&nbsp; فشل القلب</p><p>&middot;&nbsp; التهاب البنكرياس</p><p>&middot;&nbsp; مشاكل جلدية (التي من الممكن أن تتضمن داخل الفم، الأنف أو الأذنين) على سبيل المثال &quot;متلازمة ستيفن جونسون&quot; أو &quot;انحلال البشرة السمي التنخري&quot; و &quot;حمامي متعدد الأشكال&quot;</p><p>&middot;&nbsp; ارتفاع ضغط الدم</p><p><strong>غير معروفة </strong>(لا يمكن تقدير تكرار معدل حدوثها من البيانات المتاحة)</p><p>&middot;&nbsp; تفاقم حالة التهاب القولون التقرحي أو مرض كرون (التهاب القولون)</p><p>&nbsp;</p><p><strong><u>للإبلاغ عن حدوث أية تأثيرات جانبية:</u></strong></p><p><strong>&middot;&nbsp; </strong><strong>المملكة العربية السعودية</strong></p><p><strong>المركز الوطني للتيقظ والسلامة الدوائية</strong></p><p><strong>رقم الفاكس:&nbsp; </strong>&nbsp;7662-205-11-966+</p><p><strong>يرجى الاتصال بالمركز الوطني للتيقظ والسلامة الدوائية على:</strong> 2038222-11-966+<strong>&nbsp;<br />وصلة هاتف:</strong>2340-2334-2354-2353-2356-2317</p><p><strong>الهاتف المجاني: </strong>8002490000</p><p><strong>البريد الإلكتروني:</strong><strong> </strong><strong>&nbsp;</strong>npc.drug@sfda.gov.sa</p><p><strong>الموقع الإلكتروني: </strong>www.sfda.gov.sa/npc</p><p>&middot;&nbsp; <strong>دول مجلس التعاون الخليجي الأخرى:</strong> يرجى الاتصال بالجهات المختصة ذات الصلة.</p><p><strong>&nbsp;</strong></p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>-&nbsp; يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p>-&nbsp; يجب عدم تناول <strong>بروفينال </strong>بعد تاريخ انتهاء الصلاحية المذكور على العبوة والشريط.</p><p>-&nbsp; يحفظ في درجة حرارة لا تتعدى 30&deg;م.</p><p>-&nbsp; يجب عدم تناول <strong>بروفينال </strong>إذا لاحظت وجود علامات تلف واضحة.</p><p>-&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحتوي كل قرص ذي كسوة على:</p><p><strong><u>بروفينال</u></strong><u> <strong>200</strong></u></p><p>المادة الفعالة:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آيبوبروفين&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;200 ملغم</p><p>المواد غير الفعالة: نشا، حمض الاستياريك، ثنائي أكسيد السيليكون الغروي، سليلوز دقيق البلورات، بولي فينيل بيروليدون، كروس كارميلوز الصوديوم، هيبروميلوز، بولي إيثيلين جلايكول، تلك، وثنائي أكسيد التيتانيوم.</p><p><strong><u>بروفينال 400</u></strong></p><p>المادة الفعالة:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آيبوبروفين&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;400 ملغم</p><p>المواد غير الفعالة: نشا، حمض الاستيارك، ثنائي أكسيد السيليكون الغروي، سليلوز دقيق البلورات، بولي فينيل بيروليدون، كروس كارميلوز الصوديوم، هيبروميلوز، لاكتوز، ثنائي أكسيد التيتانيوم، بولي إيثيلين جلايكول، ليك طعام أحمر رقم 7، كارمويسين، إف دي وسي أزرق&nbsp;&nbsp;&nbsp; &nbsp;رقم 2، وسميثيكون.</p><p><strong><u>بروفينال 600</u></strong></p><p>المادة الفعالة:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آيبوبروفين&nbsp;&nbsp; &nbsp;&nbsp;600 ملغم</p><p>المواد غير الفعالة: نشا، حمض الاستيارك، ثنائي أكسيد السيليكون الغروي، سليلوز دقيق البلورات، بولي فينيل بيروليدون، كروس كارميلوز الصوديوم، تلك، هيبروميلوز، لاكتوز، ثنائي أكسيد التيتانيوم، بولي إيثيلين جلايكول، ليك طعام أحمر رقم 7، كارمويسين، إف دي وسي أزرق رقم 2، وسميثيكون.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>تتوفر أقراص<strong> بروفينال 200 ملغم</strong> المكسوة في عبوات تحتوي على على 20، 250، 500، و1000 قرصاً مكسواً.</p><p>تتوفر أقراص<strong> بروفينال 400 ملغم</strong> المكسوة في عبوات تحتوي على 24، 240، و1000 قرصاً مكسواً.</p><p>تتوفر أقراص<strong> بروفينال 600 ملغم</strong> المكسوة في عبوات تحتوي على 20، 40، و250 قرصاً مكسواً.</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><p>&quot;الخليج للصناعات الدوائية&quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            24/04/2016
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Profinal 600mg Film-Coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film-coated tablet contains:

Item	Material Name	Scale  (mg/ Tablet)
	Active Ingredients:	
1.		Ibuprofen	600.00
	Inactive Ingredients:	
1.		Starch (Maize Starch)	101.12
2.		Colloidal Silicon Dioxide	0.87
3.		Stearic acid	4.15
4.		Starch 1500( Pregelatinized Starch)	49.21
5.		Microcrystalline cellulose	82.35
6.		Polyvinyl pyrrolidone (Povidone)	4.93
7.		Polyvinyl pyrrolidone (Crospovidone)	8.22
8.		Croscarmellose sodium	10.00
9.		Talc	4.15
	Coating Materials:	
1.		Opadry OY-LS**	20.00
2.		Hydroxypropyl methylcellulose (Hypromellose) 	4.785
3.		Polyethylene Glycol 4000	1.100
4.		Simethicone 	0.115
5.		Purified water *	q.s

*Evaporate during drying process.
** Composition of the Opadry OY-LS
1.	Hydroxypropyl-methyl cellulose
2.	Titanium dioxide
3.	Lactose
4.	Polyethylene glycol 4000
5.	Lake food red no.7 (Ponceau 4R aluminium lake)
6.	Carmoisine aluminium lake
7.	FD&C blue no.2 (Indigo carmine aluminium lake).

For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-Coated Tablets
Description: Oblong, biconvex, pink colored, slightly mottled, mat surfaced, film coated tablets.
Marking: Face one: Plain
                 Face two: Score line



            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Profinal </strong>is indicated for its analgesic and anti-inflammatory effects in the treatment of rheumatoid arthritis (including juvenile rheumatoid arthritis or Still&#39;s disease), ankylosing spondylitis, osteoarthritis and other non-rheumatoid (seronegative) arthropathies.</p><p>In the treatment of non-articular rheumatic conditions, <strong>Profinal</strong> is indicated in periarticular conditions such as frozen shoulder (capsulitis), bursitis, tendonitis, tenosynovitis and low back pain; <strong>Profinal</strong> can also be used in soft tissue injuries such as sprains and strains.&nbsp;</p><p><strong>Profinal</strong> is also indicated for its analgesic effect in the relief of mild to moderate pain such as dysmenorrhoea, dental and post-operative pain and for symptomatic relief of headache, including migraine headache.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4).</p><p><strong><u>Adults:</u></strong> The recommended dosage of <strong>Profinal </strong>is 1200-1800 mg daily in divided doses. Some patients can be maintained on 600-1200 mg daily. In severe or acute conditions, it can be advantageous to increase the dosage until the acute phase is brought under control, provided that the total daily dose does not exceed 2400 mg in divided doses.</p><p><strong><u>Children:</u></strong> The daily dosage of <strong>Profinal </strong>is 20 mg/kg of body weight in divided doses.</p><p>In Juvenile Rheumatoid Arthritis, up to 40 mg/kg of body weight daily in divided doses may be taken.&nbsp;</p><p>Not recommended for children weighing less than 7 kg.</p><p><strong><u>Elderly:</u></strong> The elderly are at increased risk of serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patient should be monitored regularly for GI bleeding during NSAID therapy. If renal or hepatic function is impaired, dosage should be assessed individually.</p><p><strong>For oral administration.</strong> To be taken preferably with or after food, with a glass of water. <strong>Profinal </strong>tablets should be swallowed whole and not chewed, broken, crushed or sucked on to avoid oral discomfort and throat irritation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                •	Profinal is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients.
•	Profinal should not be used in patients who have previously shown hypersensitivity reactions (e.g. asthma, urticaria, angioedema or rhinitis) after taking ibuprofen, aspirin or other NSAIDs.
•	Profinal is also contraindicated in patients with a history of gastrointestinal bleeding or perforation, related to previous NSAID therapy. Profinal should not be used in patients with active, or history of, recurrent peptic ulcer or gastrointestinal haemorrhage (two or more distinct episodes of proven ulceration or bleeding).
•	Profinal should not be given to patients with conditions involving an increased tendency to bleeding.
•	Profinal is contraindicated in patients with severe heart failure, hepatic failure and renal failure (see section 4.4).
•	Profinal is contraindicated during the last trimester of pregnancy (see section 4.6).


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2, and GI and cardiovascular risks below).</p><p>Patients with rare hereditary problems of galactose intolerance, the Lapp lactose deficiency or</p><p>glucose-galactose malabsorption should not take this medication.</p><p>As with other NSAIDs, ibuprofen may mask the signs of infection.</p><p>The use of ibuprofen with concomitant NSAIDs, including cyclooxygenase-2 selective inhibitors, should be avoided due to the increased risk of ulceration or bleeding (see section 4.5).</p><p><strong><em><u>Elderly</u></em></strong></p><p>The elderly have an increased frequency of adverse reactions to NSAIDs, especially gastrointestinal bleeding and perforation, which may be fatal (see section 4.2).</p><p><strong><em><u>Paediatric population</u></em></strong></p><p>There is a risk of renal impairment in dehydrated children and adolescents.</p><p><strong><em><u>Gastrointestinal bleeding, ulceration and perforation</u></em></strong></p><p>GI bleeding, ulceration or perforation, which can be fatal, has been reported with all NSAIDs at any time during treatment, with or without warning symptoms or a previous history of serious GI events.</p><p>The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses, in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation (see section 4.3), and in the elderly. These patients should commence treatment on the lowest dose available. Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for these patients, and also for patients requiring concomitant low dose aspirin, or other drugs likely to increase gastrointestinal risk (see below and section 4.5).</p><p>Patients with a history of gastrointestinal disease, particularly when elderly, should report any unusual abdominal symptoms (especially gastrointestinal bleeding) particularly in the initial stages of treatment.</p><p>Caution should be advised in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such as warfarin, selective serotonin-reuptake inhibitors or anti-platelet agents such as aspirin (see section 4.5).</p><p>When GI bleeding or ulceration occurs in patients receiving ibuprofen, the treatment should be withdrawn.</p><p>NSAIDs should be given with care to patients with a history of ulcerative colitis or Crohn&#39;s disease as these conditions may be exacerbated (see section 4.8).</p><p><strong><em><u>Respiratory disorders</u></em></strong></p><p>Caution is required if Ibuprofen is administered to patients suffering from, or with a previous history of, bronchial asthma since NSAIDs have been reported to precipitate bronchospasm in such patients.</p><p><strong><em><u>Cardiovascular, renal and hepatic impairment</u></em></strong></p><p>The administration of an NSAID may cause a dose dependent reduction in prostaglandin formation and precipitate renal failure. Patients at greatest risk of this reaction are those with impaired renal function, cardiac impairment, liver dysfunction, those taking diuretics and the elderly. Renal function should be monitored in these patients (see also section 4.3).</p><p>Ibuprofen should be given with care to patients with a history of heart failure or hypertension since oedema has been reported in association with ibuprofen administration.</p><p><strong><em><u>Cardiovascular and cerebrovascular effects</u></em></strong></p><p>Appropriate monitoring and advice are required for patients with a history of hypertension and/or mild to moderate congestive heart failure as fluid retention and oedema have been reported in association with NSAID therapy.</p><p>Epidemiological data suggest that use of ibuprofen, particularly at a high dose (2400 mg/ daily) and in long term treatment, may be associated with a small increased risk of arterial thrombotic events such as myocardial infarction or stroke. Overall, epidemiological studies do not suggest that low dose ibuprofen (e.g. &le; 1200mg daily) is associated with an increased risk of arterial thrombotic events, particularly myocardial infarction.</p><p>Patients with uncontrolled hypertension, congestive heart failure, established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with ibuprofen after careful consideration. Similar consideration should be made before initiating longer-term treatment of patients with risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, and smoking).</p><p><strong><em><u>Renal effects</u></em></strong></p><p>Caution should be used when initiating treatment with ibuprofen in patients with considerable dehydration.</p><p>As with other NSAIDs, long-term administration of ibuprofen has resulted in renal papillary necrosis and other renal pathologic changes. Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. In these patients, administration of an NSAID may cause a dose-dependent reduction in prostaglandin formation and, secondarily, in renal blood flow, which may precipitate overt renal decompensation. Patients at greatest risk of this reaction are those with impaired renal function, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors and the elderly. Discontinuation of NSAID therapy is usually followed by recovery to the pre-treatment state.</p><p><strong><em><u>SLE and mixed connective tissue disease</u></em></strong></p><p>In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders there may be an increased risk of aseptic meningitis (see below and section 4.8).</p><p><strong><em><u>Dermatological effects</u></em></strong></p><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs (see section 4.8). Patients appear to be at highest risk of these reactions early in the course of therapy, the onset of the reaction occurring within the first month of treatment in the majority of cases. Ibuprofen should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity.</p><p><strong><em><u>Haematological effects</u></em></strong></p><p>Ibuprofen, like other NSAIDs, can interfere with platelet aggregation and has been shown to prolong bleeding time in normal subjects.</p><p><strong><em><u>Aseptic meningitis</u></em></strong></p><p>Aseptic meningitis has been observed on rare occasions in patients on ibuprofen therapy. Although it is probably more likely to occur in patients with systemic lupus erythematosus and related connective tissue diseases, it has been reported in patients who do not have an underlying chronic disease.</p><p><strong><em><u>Impaired female fertility</u></em></strong></p><p>The use of ibuprofen may impair female fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of ibuprofen should be considered.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Care should be taken in patients treated with any of the following drugs as interactions have been reported in some patients.</p><p><strong>Antihypertensives, beta-blockers and diuretics:</strong> NSAIDs may reduce the effect of anti-hypertensives, such as ACE inhibitors, beta-blockers and diuretics.</p><p>Diuretics can also increase the risk of nephrotoxicity of NSAIDs.</p><p><strong>Cardiac glycosides:</strong> NSAIDs may exacerbate cardiac failure, reduce GFR and increase plasma cardiac glycoside levels.</p><p><strong>Cholestyramine;</strong> the concomitant administration of ibuprofen and cholestyramine may reduce the absorption of ibuprofen in the gastrointestinal tract. However, the clinical significance is unknown.</p><p><strong>Lithium:</strong> Decreased elimination of lithium.</p><p><strong>Methotrexate:</strong> NSAIDs may inhibit the tubular secretion of methotrexate and reduce clearance of methotrexate.</p><p><strong>Ciclosporin:</strong> Increased risk of nephrotoxicity.</p><p><strong>Mifepristone:</strong> A decrease in the efficacy of the medicinal product can theoretically occur due to the antiprostaglandin properties of NSAIDs. Limited evidence suggests that coadministration of NSAIDs on the day of prostaglandin administration does not adversely influence the effects of mifepristone or the prostaglandin on cervical ripening or uterine contractility and does not reduce the clinical efficacy of medicinal termination of pregnancy.</p><p><strong>Other analgesics and cyclooxygenase-2 selective inhibitors:</strong> Avoid concomitant use of two or more NSAIDs, including Cox-2 inhibitors, as this may increase the risk of adverse effects (see section 4.4).</p><p><strong>Aspirin:</strong> As with other products containing NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential of increased adverse effects.</p><p>Experimental data suggest that ibuprofen may inhibit the effect of low dose aspirin on platelet aggregation when they are dosed concomitantly. However, the limitations of these data and the uncertainties regarding extrapolation of ex vivo data to the clinical situation imply that no firm conclusions can be made for regular ibuprofen use, and no clinically relevant effect is considered to be likely for occasional use (see section 5.1).</p><p><strong>Corticosteroids:</strong> Increased risk of gastrointestinal ulceration or bleeding with NSAIDs (see section 4.4).</p><p><strong>Anticoagulants:</strong> NSAIDs may enhance the effects of anticoagulants, such as warfarin (see section 4.4).</p><p><strong>Quinolone antibiotics:</strong> Animal data indicate that NSAIDs can increase the risk of convulsions associated with quinolone antibiotics. Patients taking NSAIDs and quinolones may have an increased risk of developing convulsions.</p><p><strong>Sulfonylureas:</strong> NSAIDs may potentiate the effects of sulfonylurea medications. There have been rare reports of hypoglycaemia in patients on sulfonylurea medications receiving ibuprofen.</p><p><strong>Anti-platelet agents and selective serotonin reuptake inhibitors (SSRIs):</strong> Increased risk of gastrointestinal bleeding with NSAIDs (see section 4.4).</p><p><strong>Tacrolimus:</strong> Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus.</p><p><strong>Zidovudine:</strong> Increased risk of haematological toxicity when NSAIDs are given with zidovudine. There is evidence of an increased risk of haemarthroses and haematoma in HIV(+) haemophiliacs receiving concurrent treatment with zidovudine and ibuprofen.</p><p><strong>Aminoglycosides:</strong> NSAIDs may decrease the excretion of aminoglycosides.</p><p><strong>Herbal extracts:</strong> Ginkgo biloba may potentiate the risk of bleeding with NSAIDs.</p><p><strong>CYP2C9 Inhibitors:</strong> Concomitant administration of ibuprofen with CYP2C9 inhibitors may increase the exposure to ibuprofen (CYP2C9 substrate). In a study with voriconazole and fluconazole (CYP2C9 inhibitors), an increased S(+)-ibuprofen exposure by approximately 80 to 100% has been shown. Reduction of the ibuprofen dose should be considered when potent CYP2C9 inhibitors are administered concomitantly, particularly when high-dose ibuprofen is administered with either voriconazole or fluconazole.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em><u>Pregnancy</u></em></strong></p><p>Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or embryo/foetal development. Data from epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after the use of a prostaglandin synthesis inhibitor in early pregnancy. In animals, the administration of a prostaglandin synthesis inhibitor has been shown to result in increased pre- and post-implantation losses and embryo/foetal lethality. In addition, increased incidences of various malformations, including cardiovascular, have been reported in animals given a prostaglandin synthesis inhibitor during the organogenetic period.</p><p>During the first and second trimester of pregnancy, ibuprofen should not be given unless clearly necessary. If ibuprofen is used by a woman attempting to conceive, or during the first or second trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible.</p><p>During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the foetus to the following:</p><p>&middot;&nbsp;&nbsp; Cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension)</p><p>&middot;&nbsp;&nbsp; Renal dysfunction, which may progress to renal failure with oligohydramnios.</p><p>At the end of pregnancy, prostaglandin synthesis inhibitors may expose the mother and the neonate to the following:</p><p>&middot;&nbsp;&nbsp; Possible prolongation of bleeding time</p><p>&middot;&nbsp;&nbsp; Inhibition of uterine contractions, which may result in delayed or prolonged labour.</p><p>Consequently, ibuprofen is contraindicated during the third trimester of pregnancy.</p><p><strong><em><u>Lactation</u></em></strong></p><p>In the limited studies so far available, NSAIDs can appear in the breast milk in very low concentrations. NSAIDs should, if possible, be avoided when breastfeeding.</p><p>See section 4.4 Special warnings and precautions for use, regarding female fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects such as dizziness, drowsiness, fatigue and visual disturbances are possible after taking NSAIDs. If affected, patients should not drive or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Gastrointestinal disorders:</strong> The most commonly observed adverse events are gastrointestinal in nature. Peptic ulcers, perforation or GI bleeding, sometimes fatal, particularly in the elderly, may occur (see section 4.4). Nausea, vomiting, diarrhoea, flatulence, constipation, dyspepsia, abdominal pain, melaena, haematemesis, ulcerative stomatitis, gastrointestinal haemorrhage and exacerbation of colitis and Crohn&#39;s disease (see section 4.4) have been reported following ibuprofen administration. Less frequently, gastritis, duodenal ulcer, gastric ulcer and gastrointestinal perforation have been observed.</p><p><strong>Immune system disorders:</strong> Hypersensitivity reactions have been reported following treatment with NSAIDs. These may consist of (a) nonspecific allergic reaction and anaphylaxis, (b) respiratory tract reactivity comprising asthma, aggravated asthma, bronchospasm or dyspnoea, or (c) assorted skin disorders, including rashes of various types, pruritus, urticaria, purpura, angioedema and, very rarely, erythema multiforme, bullous dermatoses (including StevensJohnson syndrome and toxic epidermal necrolysis).</p><p><strong>Cardiac disorders and vascular disorders:</strong> Oedema, hypertension and cardiac failure have been reported in association with NSAID treatment. Clinical studies suggest that use of ibuprofen, particularly at high dose (2400 mg/day) may be associated with a small increased risk of arterial thrombotic events such as myocardial infarction or stroke (see section 4.4)<em>.</em></p><p><strong>Infections and infestations:</strong> Rhinitis and aseptic meningitis (especially in patients with existing autoimmune disorders, such as systemic lupus erythematosus and mixed connective tissue disease) with symptoms of stiff neck, headache, nausea, vomiting, fever or disorientation (see section 4.4).</p><p>Exacerbation of infectionrelated inflammations coinciding with the use of NSAIDs has been described. If signs of an infection occur or get worse during use of Ibuprofen the patient is therefore recommended to go to a doctor without delay.</p><p><strong>Skin and subcutaneous tissue disorders:</strong> In exceptional cases, severe skin infections and softtissue complications may occur during a varicella infection (see also &quot;Infections and infestations&quot;)</p><p>The following adverse reactions possibly related to ibuprofen and displayed by MedDRA frequency convention and system organ classification. Frequency groupings are classified according to the subsequent conventions: very common (&ge;1/10), Common (&ge;1/100 to &lt;1/10), Uncommon (&ge;1/1,000 to &lt;1/100), Rare (&ge;1/10,000 to &lt;1/1,000), Very rare (&lt;1/10,000) and Not known (cannot be estimated from the available data).</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System organ class</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse reaction</strong></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p><p>Infections and infestations</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Rhinitis</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Meningitis aseptic</p><p>(see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Blood and lymphatic</p><p>system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Rare</p></td><td style="vertical-align:top"><p>Leukopenia, thrombocytopenia, neutropenia, agranulocytosis, aplastic anaemia , haemolytic anaemia</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Anaphylactic reaction</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Insomnia, anxiety</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Depression, confusional state</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Common</p><p>&nbsp;</p><p><strong><em><u>&nbsp;</u></em></strong></p></td><td style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Headache, dizziness</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Paraesthesia, somnolence</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Optic neuritis</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Visual impairment</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Toxic optic neuropathy</p></td></tr><tr><td style="vertical-align:top"><p>Ear and labyrinth disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Hearing impaired , tinnitus, vertigo</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Asthma, bronchospasm, dyspnoea</p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Dyspepsia, diarrhoea, nausea, vomiting, abdominal pain, flatulence, constipation, melaena, haematemesis, gastrointestinal haemorrhage</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Gastritis, duodenal ulcer, gastric ulcer, mouth ulceration, gastrointestinal perforation</p></td></tr><tr><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Pancreatitis</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Exacerbation of Colitis and Crohn&acute;s disease</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Hepatitis, jaundice, hepatic function abnormal</p></td></tr><tr><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Hepatic failure</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Rash</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Urticaria, pruritus, purpura, angioedema,</p><p>photosensitivity reaction</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Severe forms of skin reactions ( e.g. Erythema multiforme, bullous reactions, including StevensJohnson</p><p>syndrome,and toxic epidermal</p><p>necrolysis)</p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Nephrotoxity in various forms</p><p>e.g.Tubulointerstitial nephritis, nephrotic syndrome and renal failure</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Fatigue</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Oedema</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Cardiac failure, myocardial infarction (also see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Hypertension</p></td></tr></tbody></table><p><strong><em><u>&nbsp;</u></em></strong></p><p><strong><em><u>To report any side effect(s)</u></em></strong><strong><em><u>: </u></em></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax:</strong> +966-11-205-7662</p><p><strong>Call NPC at</strong> +966-11-2038222, <strong>Exts:</strong> 2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone:</strong> 8002490000</p><p><strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p><strong>Website:</strong> www.sfda.gov.sa/npc</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em><u>Toxicity</u></em></strong></p><p>Signs and symptoms of toxicity have generally not been observed at doses below 100 mg/kg in children or adults. However, supportive care may be needed in some cases. Children have been observed to manifest signs and symptoms of toxicity after ingestion of 400 mg/kg or greater.</p><p><strong><em><u>Symptoms</u></em></strong></p><p>Most patients who have ingested significant amounts of ibuprofen will manifest symptoms within 4 to 6 hours.</p><p>The most frequently reported symptoms of overdose include nausea, vomiting, abdominal pain, lethargy and drowsiness. Central nervous system (CNS) effects include headache, tinnitus, dizziness, convulsion, and loss of consciousness. Nystagmus, metabolic acidosis, hypothermia, renal effects, gastrointestinal bleeding, coma, apnoea, diarrhoea and depression of the CNS and respiratory system have also been rarely reported. Disorientation, excitation, fainting and cardiovascular toxicity, including hypotension, bradycardia and tachycardia have been reported. In cases of significant overdose, renal failure and liver damage are possible. Large overdoses are generally well tolerated when no other drugs are being taken.</p><p><strong><em><u>Therapeutic measures</u></em></strong></p><p>Patients should be treated symptomatically as required. Within one hour of ingestion of a potentially toxic amount, activated charcoal should be considered. Alternatively, in adults, gastric lavage should be considered within one hour of ingestion of a potentially life-threatening overdose.</p><p>Good urine output should be ensured.</p><p>Renal and liver function should be closely monitored.</p><p>Patients should be observed for at least four hours after ingestion of potentially toxic amounts.</p><p>Frequent or prolonged convulsions should be treated with intravenous diazepam. Other measures may be indicated by the patient&#39;s clinical condition.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic classification: Antiinflammatory and antirheumatic products, nonsteroidal; propionic acid derivatives.</p><p>ATC code: M01AE01</p><p>Ibuprofen is a propionic acid derivative with analgesic, anti-inflammatory and anti-pyretic activity. The drug&#39;s therapeutic effects as an NSAID is thought to result from its inhibitory effect on the enzyme cyclo-oxygenase, which results in a marked reduction in prostaglandin synthesis.</p><p>Experimental data suggest that ibuprofen may inhibit the effect of low dose aspirin on platelet aggregation when they are dosed concomitantly. In one study, when a single dose of ibuprofen 400mg was taken within 8 hours before or within 30 minutes after immediate release aspirin dosing (81mg), a decreased effect of aspirin on the formation of thromboxane or platelet aggregation occurred. However, the limitations of these data and the uncertainties regarding extrapolation of ex vivo data to the clinical situation imply that no firm conclusions can be made for regular ibuprofen use, and no clinically relevant effect is considered to be likely for occasional ibuprofen use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ibuprofen is rapidly absorbed from the gastrointestinal tract, peak serum concentrations occurring 1-2 hours after administration. The elimination half-life is approximately 2 hours.</p><p>Ibuprofen is metabolised in the liver to two inactive metabolites and these, together with unchanged ibuprofen, are excreted by the kidney either as such or as conjugates. Excretion by the kidney is both rapid and complete.</p><p>Ibuprofen is extensively bound to plasma proteins.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" align="left"><tbody><tr><td><p><strong><u>Inactive Ingredients:</u></strong></p></td></tr><tr><td><p><strong>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>Starch (Maize Starch)</p></td></tr><tr><td><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Colloidal Silicon Dioxide</p></td></tr><tr><td><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stearic acid</p></td></tr><tr><td><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Starch 1500( Pregelatinized Starch)</p></td></tr><tr><td><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Microcrystalline cellulose</p></td></tr><tr><td><p>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Polyvinyl pyrrolidone (Povidone)</p></td></tr><tr><td><p>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Polyvinyl pyrrolidone (Crospovidone)</p></td></tr><tr><td><p>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Croscarmellose sodium</p></td></tr><tr><td><p>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Talc</p></td></tr><tr><td><p><strong><u>Coating Materials:</u></strong></p></td></tr><tr><td><ol><li>Opadry OY-LS**</li></ol></td></tr><tr><td><ol><li>Hydroxypropyl methyl cellulose (Hypromellose)</li></ol></td></tr><tr><td><ol><li>Polyethylene Glycol 4000</li></ol></td></tr><tr><td><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Simethicone</p></td></tr><tr><td><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purified water *</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>*Evaporate during drying process.</p><p><strong><u>** Composition of the Opadry OY-LS</u></strong></p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hydroxypropyl-methyl cellulose</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Titanium dioxide</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lactose</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Polyethylene glycol 4000</p><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lake food red no.7 (Ponceau 4R aluminium lake)</p><p>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Carmoisine aluminium lake</p><p>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; FD&amp;C blue no.2 (Indigo carmine aluminium lake).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                60 months from the date of manufacturing.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30˚C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 tablets in a blister, 2 blisters packed in a printed carton along with a leaflet.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 tablets in a blister, 4 blisters packed in a printed carton along with a leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street
Ras Al Khaimah - United Arab Emirates
P.O. Box 997
Tel. No.:   (9717) 2 461 461
Fax No.:   (9717) 2 462 462

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24. April. 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>